Peaks of Interest
Daniel W. Armstrong, a professor of chemistry and biochemistry at the University of Texas Arlington in Arlington, Texas, is to receive the 2014 American Chemical Society Award in Separations Science and Technology.
Daniel W. Armstrong to Receive ACS Award in Separation Science and Technology 2014
Daniel W. Armstrong, a professor of chemistry and biochemistry at the University of Texas Arlington in Arlington, Texas, is to receive the 2014 American Chemical Society Award in Separations Science and Technology. This is the second time this year that the ACS has recognized the work of Armstrong — in August last year he was selected to join the ACS Class of Fellows 2013.
The award, sponsored by Waters Corporation, recognizes "the development of novel applications with major impacts and/or the practical implementations of modern advancements in the field of separation science and technology." It will be presented to Armstrong on March 17 at the ACS national conference in Dallas, Texas.
Armstrong is thought of as a leader in his field and is considered to be the "father" of pseudo-phase separations — a type of chromatography that lowers costs, volatility, and toxicity while providing higher selectivity than other analytical methods. His commercialized innovations are applied across the drug development, environmental analysis, and petrochemical industries.
In his career, Armstrong has developed more than 30 different chromatography columns — a gas chromatography column that he developed is now part of the Rosetta mission of the European Space Agency exploring the composition of comets in space.
Purdue Research Foundation Invests in Two Start-up Companies
The Purdue Research Foundation (West Lafayette, Indiana) has awarded $150,000 in investment to two companies that have licensed Purdue University Innovations: Telos Discovery Systems Inc., and bioVidria Inc. The investment is from the Emerging Innovations Fund, which was set up in 2008 to accelerate the commercialization of early stage technologies in the Purdue community.
The company bioVidria Inc., received $75,000. It is based on the work of Mary J. Wirth, the W. Brooks Fortune Distinguished Professor of Analytical Chemistry in the Department of Chemistry. The company focuses on developing new materials for chromatography, specifically protein analysis, for the pharmaceutical and agricultural industries.
Telos Discovery Systems Inc., also received $75,000. The company is a boutique equipment manufacturer that supports basic and discovery medical research. The company is based on the work of Joseph Garner, a former Purdue associate professor in the Department of Animal Sciences.
Elizabeth Hart-Wells, assistant vice president and director of the Purdue Office of Technology Commercialization said: "The fund makes seed investments and early-stage investments in the form of convertible debt and/or warrants, with a goal of accelerating the commercialization of early-stage innovations."
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
Liquid Chromatography to Analyze Vitamin D Proteins in Psoriasis Patients
January 21st 2025Can a protein involved in delivering Vitamin D to target tissues have an altered serum profile in psoriasis patients with cardiovascular disease? Researchers used liquid chromatography (LC) to help find out.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
A Guide To Finding the Ideal Syringe and Needle
January 20th 2025Hamilton has produced a series of reference guides to assist science professionals in finding the best-suited products and configurations for their applications. The Syringe and Needle Reference Guide provides detailed information on Hamilton Company’s full portfolio of syringes and needles. Everything from cleaning and preventative maintenance to individual part numbers are available for review. It also includes selection charts to help you choose between syringe terminations like cemented needles and luer tips.
